JP2014532416A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532416A5
JP2014532416A5 JP2014539105A JP2014539105A JP2014532416A5 JP 2014532416 A5 JP2014532416 A5 JP 2014532416A5 JP 2014539105 A JP2014539105 A JP 2014539105A JP 2014539105 A JP2014539105 A JP 2014539105A JP 2014532416 A5 JP2014532416 A5 JP 2014532416A5
Authority
JP
Japan
Prior art keywords
murine
human
endogenous
gene
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532416A (ja
JP6120451B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062379 external-priority patent/WO2013063556A1/en
Publication of JP2014532416A publication Critical patent/JP2014532416A/ja
Publication of JP2014532416A5 publication Critical patent/JP2014532416A5/ja
Application granted granted Critical
Publication of JP6120451B2 publication Critical patent/JP6120451B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539105A 2011-10-28 2012-10-29 ヒト化il−6および/またはil−6受容体 Active JP6120451B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US61/552,900 2011-10-28
US201161556579P 2011-11-07 2011-11-07
US61/556,579 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016224713A Division JP2017035115A (ja) 2011-10-28 2016-11-18 ヒト化il−6および/またはil−6受容体

Publications (3)

Publication Number Publication Date
JP2014532416A JP2014532416A (ja) 2014-12-08
JP2014532416A5 true JP2014532416A5 (enExample) 2015-12-03
JP6120451B2 JP6120451B2 (ja) 2017-04-26

Family

ID=47295138

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014539105A Active JP6120451B2 (ja) 2011-10-28 2012-10-29 ヒト化il−6および/またはil−6受容体
JP2016224713A Pending JP2017035115A (ja) 2011-10-28 2016-11-18 ヒト化il−6および/またはil−6受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016224713A Pending JP2017035115A (ja) 2011-10-28 2016-11-18 ヒト化il−6および/またはil−6受容体

Country Status (27)

Country Link
US (10) US8878001B2 (enExample)
EP (2) EP2818478B1 (enExample)
JP (2) JP6120451B2 (enExample)
KR (2) KR102084927B1 (enExample)
CN (2) CN108866101A (enExample)
AU (1) AU2015207889B2 (enExample)
BR (1) BR112014008529A2 (enExample)
CA (1) CA2853731C (enExample)
CY (2) CY1116614T1 (enExample)
DK (2) DK2818478T3 (enExample)
ES (2) ES2624605T3 (enExample)
HR (2) HRP20141192T1 (enExample)
HU (1) HUE033400T2 (enExample)
IL (4) IL231896B (enExample)
IN (1) IN2014CN03920A (enExample)
LT (1) LT2818478T (enExample)
MX (1) MX358390B (enExample)
MY (2) MY186903A (enExample)
PL (2) PL2818478T3 (enExample)
PT (2) PT2818478T (enExample)
RS (2) RS53683B1 (enExample)
RU (2) RU2634417C2 (enExample)
SG (3) SG11201400945UA (enExample)
SI (2) SI2663575T1 (enExample)
SM (2) SMT201700222T1 (enExample)
WO (1) WO2013063556A1 (enExample)
ZA (1) ZA201402635B (enExample)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541646B2 (en) 2009-10-06 2013-09-24 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
PT4233537T (pt) 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
PL2818478T3 (pl) 2011-10-28 2017-09-29 Regeneron Pharmaceuticals, Inc. Humanizowane il-6 i receptor il-6
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
IN2015DN02032A (enExample) 2012-09-07 2015-08-14 Univ Yale
SG11201501924UA (en) * 2012-09-13 2015-05-28 Chugai Pharmaceutical Co Ltd Gene knock-in non-human animal
ES2884598T3 (es) * 2012-11-05 2021-12-10 Regeneron Pharma Animales no humanos modificados genéticamente y métodos de uso de los mismos
CA2900832A1 (en) 2013-02-20 2014-08-28 Regeneron Pharmaceuticals, Inc. Mice expressing humanized t-cell co-receptors
CA2900824A1 (en) 2013-02-22 2014-08-28 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
MX368931B (es) * 2013-09-23 2019-10-22 Regeneron Pharma Animales no humanos que tienen un gen de proteina reguladora de señal humanizado.
AU2014337526B2 (en) * 2013-10-15 2020-09-10 Regeneron Pharmaceuticals, Inc. Humanized IL-15 animals
US20150143558A1 (en) * 2013-11-19 2015-05-21 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
BR112016011004A2 (pt) * 2013-11-19 2017-12-05 Regeneron Pharma animal roedor geneticamente modificado, célula tronco embrionária de roedor, embrião de roedor, e, métodos para fabricar um animal roedor e para enxertar células humanas em um camundongo
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
WO2016039801A1 (en) 2014-01-31 2016-03-17 Boehringer Ingelheim International Gmbh Novel anti-baff antibodies
RU2700484C2 (ru) 2014-04-08 2019-09-17 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы
CN106659146B (zh) 2014-05-05 2020-06-23 再生元制药公司 人源化c5和c3动物
NO2785538T3 (enExample) 2014-05-07 2018-08-04
PT3482629T (pt) 2014-05-19 2021-02-18 Univ Yale Animais não humanos geneticamente modificados que expressam epo humana
AU2015266841C1 (en) 2014-05-30 2018-06-07 Regeneron Pharmaceuticals, Inc. Humanized dipeptidyl peptidase IV (DPP4) animals
EP3683238A1 (en) * 2014-06-19 2020-07-22 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized programmed cell death 1 gene
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
KR102659123B1 (ko) 2014-11-24 2024-04-22 리제너론 파마슈티칼스 인코포레이티드 인간화 cd3 복합체를 발현하는 비인간 동물
FI3850946T3 (fi) * 2014-12-05 2023-12-28 Regeneron Pharma Ei-ihmiseläimiä, joilla on humanisoitu erilaistumisklusterin 47 geeni
EP3808775B1 (en) 2014-12-09 2024-04-17 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 274 gene
US10101811B2 (en) 2015-02-20 2018-10-16 Ultrahaptics Ip Ltd. Algorithm improvements in a haptic system
WO2016132144A1 (en) 2015-02-20 2016-08-25 Ultrahaptics Ip Limited Perceptions in a haptic system
RU2732628C2 (ru) 2015-04-06 2020-09-21 Регенерон Фармасьютикалз, Инк. Опосредованные гуманизированными т-клетками иммунные ответы у не относящихся к человеку животных
PT3282835T (pt) 2015-04-13 2023-07-25 Univ Yale Ratinhos knockin de sirpa-il15 humanizadas e métodos de utilização dos mesmos
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
KR102454546B1 (ko) 2015-11-20 2022-10-14 리제너론 파마슈티칼스 인코포레이티드 인간화 림프구 활성화 유전자 3을 갖는 비인간 동물
KR20250133801A (ko) 2015-12-08 2025-09-08 리제너론 파마슈티칼스 인코포레이티드 효소 내재화 조성물 및 방법
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
EP3411392B1 (en) 2016-02-04 2021-12-29 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered angptl8 gene
EP3895529B1 (en) 2016-02-29 2026-04-29 Regeneron Pharmaceuticals, Inc. Rodents having a humanized tmprss gene
KR102483193B1 (ko) 2016-06-03 2023-01-04 리제너론 파마슈티칼스 인코포레이티드 외인성 말단 데옥시뉴클레오타이드 전달효소를 발현하는 비인간 동물
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (zh) * 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
CN108467873B (zh) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
WO2018177441A1 (en) * 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
JP7139419B2 (ja) 2017-09-29 2022-09-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ttr遺伝子座を含む非ヒト動物および使用方法
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
IL274740B2 (en) 2017-11-30 2024-06-01 Regeneron Pharma Non-human animals comprising a humanized trkb locus
WO2019122912A1 (en) 2017-12-22 2019-06-27 Ultrahaptics Limited Tracking in haptic systems
US11704983B2 (en) 2017-12-22 2023-07-18 Ultrahaptics Ip Ltd Minimizing unwanted responses in haptic systems
WO2019190990A1 (en) 2018-03-26 2019-10-03 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
SG11202010752VA (en) 2018-05-02 2020-11-27 Ultrahaptics Ip Ltd Blocking plate structure for improved acoustic transmission efficiency
IL315703A (en) 2018-07-16 2024-11-01 Regeneron Pharma Non-human animal models of DITRA disease and their uses
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
CN111837036B (zh) * 2018-12-17 2024-06-18 百奥赛图江苏基因生物技术有限公司 具有人或嵌合基因的基因修饰的非人动物
US12373033B2 (en) 2019-01-04 2025-07-29 Ultrahaptics Ip Ltd Mid-air haptic textures
WO2020141330A2 (en) 2019-01-04 2020-07-09 Ultrahaptics Ip Ltd Mid-air haptic textures
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
ES2966625T3 (es) 2019-04-04 2024-04-23 Regeneron Pharma Roedores que comprenden un locus del factor de coagulación 12 humanizado
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
WO2020240876A1 (ja) * 2019-05-27 2020-12-03 株式会社トランスジェニック エクソンヒト化マウス
US11891618B2 (en) 2019-06-04 2024-02-06 Regeneron Pharmaceuticals, Inc. Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use
CA3137764A1 (en) 2019-06-07 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
JP7611244B2 (ja) 2019-10-13 2025-01-09 ウルトラリープ リミテッド 仮想マイクロフォンによる動的キャッピング
US11169610B2 (en) 2019-11-08 2021-11-09 Ultraleap Limited Tracking techniques in haptic systems
CN111304246B (zh) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 一种人源化细胞因子动物模型、制备方法及应用
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
CN115175559A (zh) * 2020-01-28 2022-10-11 瑞泽恩制药公司 包含人源化pnpla3基因座的非人动物及其使用方法
CA3167557A1 (en) 2020-04-21 2021-10-28 Davor Frleta Non-human animals having a humanized cxcl13 gene
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
US11886639B2 (en) 2020-09-17 2024-01-30 Ultraleap Limited Ultrahapticons
US12376573B2 (en) 2021-03-31 2025-08-05 Regeneron Pharmaceuticals, Inc. Genetically modified mice comprising humanized cellular immune system components with improved diversity of TCRB repertoire
US12517585B2 (en) 2021-07-15 2026-01-06 Ultraleap Limited Control point manipulation techniques in haptic systems
EP4593590A1 (en) 2022-09-29 2025-08-06 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes
WO2025212991A1 (en) 2024-04-05 2025-10-09 Regeneron Pharmaceuticals, Inc. Rodent models of disease
WO2025250495A1 (en) 2024-05-28 2025-12-04 Regeneron Pharmaceuticals, Inc. Acceleration of human hepatocyte engraftment in humanized liver animals by supplementing paracrine ligands or agonists that activate human liver regeneration signals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10509586A (ja) * 1994-10-14 1998-09-22 ベーアーエスエフ アクツィエンゲゼルシャフト 機能的に破壊されたインターロイキン−1β変換酵素遺伝子を有するトランスジェニック非ヒト動物
PL182089B1 (en) 1994-10-21 2001-11-30 Chugai Pharmaceutical Co Ltd Pharmaceutic compositions for treating diseases caused by production of il-6
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (zh) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 用能产生人IgGl重链-κ轻链小鼠作为制备人源化单克隆抗体和应用
WO2006044962A1 (en) 2004-10-19 2006-04-27 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
NZ587107A (en) 2006-06-02 2012-05-25 Regeneron Pharma High affinity antibodies to human il-6 receptor
ES2378407T3 (es) * 2006-09-01 2012-04-12 Therapeutic Human Polyclonals, Inc. Aumento de la expresión de inmunoglobulina humana o humanizada en animales transgénicos no humanos
FR2942218A1 (fr) 2009-02-13 2010-08-20 Eurocave Sa Appareil de service au verre d'un liquide, notamment de vin
US8541646B2 (en) * 2009-10-06 2013-09-24 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
NO2516457T3 (enExample) * 2009-12-21 2018-08-11
PT4233537T (pt) 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
BR112014007484A2 (pt) 2011-09-30 2017-04-04 Chugai Pharmaceutical Co Ltd molécula de ligação a antígeno de indução de resposta imune a antígeno alvo
ES2741649T3 (es) 2011-10-28 2020-02-11 Regeneron Pharma Ratones con complejo mayor de histocompatibilidad modificado genéticamente
RS63220B1 (sr) 2011-10-28 2022-06-30 Regeneron Pharma Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc)
PL2818478T3 (pl) 2011-10-28 2017-09-29 Regeneron Pharmaceuticals, Inc. Humanizowane il-6 i receptor il-6

Similar Documents

Publication Publication Date Title
WO2013063556A4 (en) Humanized il-6 and il-6 receptor
JP2015523863A5 (enExample)
US12369570B2 (en) Humanized IL-15 animals
Pisitkun et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis
RU2014148107A (ru) Грызуны с гуманизированным il-7
Takemoto et al. Sycp2 is essential for synaptonemal complex assembly, early meiotic recombination and homologous pairing in zebrafish spermatocytes
RU2016123708A (ru) Отличные от человека животные, содержащие гуманизированный ген фактора активации в-клеток
SI3027015T1 (en) HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS
JP2015510769A5 (enExample)
KR102659123B1 (ko) 인간화 cd3 복합체를 발현하는 비인간 동물
WO2015077072A4 (en) Non-human animals having a humanized a proliferation-inducing ligand gene
NZ731471A (en) Non-human animals having a humanized cluster of differentiation 47 gene
NZ712508A (en) Non-human animals expressing ph-sensitive immunoglobulin sequences
Wang et al. Comparative evolutionary genomics of the STAT family of transcription factors
HRP20200899T1 (hr) Neljudske životinje koje imaju humanizirane fc-gamma receptore
US11534502B2 (en) Genetically modified non-human animal with human or chimeric TIGIT
Bollmer et al. Social and extra-pair mating in relation to major histocompatibility complex variation in common yellowthroats
WO2019114768A1 (en) GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD3e
Aida et al. Translating human genetics into mouse: The impact of ultra‐rapid in vivo genome editing
RU2018146313A (ru) Грызуны с условными мутантными аллелями acvr1
RU2018109739A (ru) Трансгенное животное для получения антител, имеющих общую легкую цепь
Beatty et al. Comparative analysis of meningeal transcriptomes in birds: Potential pathways of resilience to repeated impacts
RU2024118368A (ru) Гуманизированные мыши с нокином sirpa-il15 и способы их использования
HK40006180A (en) Humanized il-15 animals
Watanabe et al. " Pathogenesis of autosomal dominant hereditary spastic paraplegia (SPG6) revealed by a rat model": Erratum.